NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Altaris to Acquire Simulations Plus for $375 Million in All-Cash Deal

Shareholders get $18.50 per share. The company is expected to combine with Chemical Computing Group after closing. Deal expected to close in Q4 2026.

Altaris to Acquire Simulations Plus for $375 Million in All-Cash Deal
simulations-plus.com
Already have an account? Sign in.
06/16/2026 · 9:40 AM
SLP
/ Read more

Feed↓

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada
07/21/2026 · 3:53 PM

PolyPid Secures $320 Million Partnership with Azurity for D-PLEX100 in U.S. and Canada

Roth Capital maintains a Buy rating with a $9 price target despite the post-deal share decline.

/ Subscriber only
BMO Bullish on Trevi Therapeutics: Sees First-in-Class Potential for Haduvio in IPF Cough
07/21/2026 · 1:18 PM

BMO Bullish on Trevi Therapeutics: Sees First-in-Class Potential for Haduvio in IPF Cough

BMO Capital gives Trevi Therapeutics an Outperform rating and $36 target, citing strong potential for Haduvio as a first-in-class treatment for chronic cough in idiopathic pulmonary fibrosis.

/ Subscriber only
TSMC Announces Up to 10% Price Hike for Advanced Chips Starting 2027
Featured/ 07/21/2026 · 12:54 PM

TSMC Announces Up to 10% Price Hike for Advanced Chips Starting 2027

Analyst forecasts show Intel and Samsung struggling to close the gap on A16 and N2 technology.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe